🇺🇸 FDA
Patent

US 11773083

Solid state forms of Belumosudil and Belumosudil salts

granted A61PA61P17/00

Quick answer

US patent 11773083 (Solid state forms of Belumosudil and Belumosudil salts) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Grant date
Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P17/00